Home
Conditions
Maintenance Therapy

Clinical trial condition

Maintenance Therapy

Explore clinical trials studying Maintenance Therapy. Study availability and eligibility vary by location and protocol.

13 public trials 7 recruiting studies

Refine in advanced search Browse all conditions

Maintenance Therapy trial results

Recruiting

Maintenance Therapy With Toripalimab and Capecitabine Versus Capecitabine Alone in High-risk Nasopharyngeal Carcinoma

NCT06277050

Conditions: Carcinoma, Head and Neck Neoplasms, High-Risk Cancer, +13 more
Locations: Ganzhou Cancer Hospital Ganzhou, Jiangxi, China

First Affiliated hospital of Gannan Medical University Guangzhou, Jiangxi, China

Department of Nasopharyngeal Carcinoma, Jiangxi Cancer Hospital Nanchang, None Selected, China

View Trial Details

Recruiting

Efficacy and Safety of Autologous Peptide-induced Active Immunity in AML Maintenance Therapy

NCT07551037

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +7 more
Locations: Fujian Medical University Union Hospital Fuzhou, Fujian, China

View Trial Details

Recruiting

A Real-world Study on the Efficacy and Safety of Menin Inhibitors as Maintenance After Allo-HSCT

NCT07559695

Conditions: Acute Leukemia, KMT2A Rearrangement, Maintenance Therapy, +4 more
Locations: The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China

View Trial Details

Recruiting

MRD-guided Maintenance Post-HCT: Gilteritini vs Sorafenib

NCT07463651

Conditions: Acute Myeloid Leukemia (AML), Allogeneic Hematopoietic Cell Transplantation (HCT), FLT3-ITD Mutation, +10 more
Locations: the First Affiliated Hosptital of Soochow University Suzhou, Jiangsu, China

Ruijin Hospital, Shanghai Jiaotong University School of Medicine Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Phase 2 Trial of BN104 as Post-HSCT Maintenance in Acute Leukemia

NCT07101497

Conditions: Acute Leukemia, KMT2A Rearrangement, Maintenance Therapy, +4 more
Locations: The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China

View Trial Details

Recruiting

A Multicenter, Prospective, Phase II Study of Zanubrutinib for Maintenance in Patients With Mantle Cell Lymphoma

NCT06341556

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China

Shanghai Cancer Center Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Efficacy and Safety for Telitacicept in the Remission Maintenance Treatment of ANCA-associated Vasculitis (TTCAZAREM)

NCT05965284

Conditions: ANCA-associated Vasculitis, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, +9 more
Locations: Peking Union Medical College Hospital Beijing, Beijing Municipality, China

View Trial Details

Not Yet Recruiting

Maintenance Chemotherapy With S-1 vs. Observation After Adjuvant Therapy for Resected Pancreatic Cancer With High Risk of Recurrence/Metastasis

NCT06779318

Conditions: Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +8 more
Locations: The First Affiliated Hospital with Nanjing Medical University Nanjing, Jiangsu, China

View Trial Details

Not Yet Recruiting

Fruquintinib Combined With PD-1 Inhibitor as First-line Maintenance Therapy for Advanced Gastric Cancer

NCT06888037

Conditions: First-line Therapy, Fruquintinib, GEJ Adenocarcinoma, +3 more
Locations: Ruijin Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Completed

Nevirapine / Lamivudine for HIV Maintenance Therapy

NCT07014189

Conditions: Antiretroviral Treatment, Blood-Borne Infections, Communicable Diseases, +14 more
Locations: Cantonal Hospital St. Gallen Sankt Gallen, Switzerland

View Trial Details

Maintenance Therapy

Maintenance Therapy trial results

Related conditions